What is the Cost of Chronic Disease in America?
Chronic disease is the single greatest financial weight pressing down on the United States healthcare system — and it has been for decades. Yet in 2026, the numbers have reached a scale that demands urgent reckoning from policymakers, employers, insurers, and every American household. The Centers for Disease Control and Prevention (CDC) defines chronic diseases as conditions lasting one year or more that require ongoing medical attention, limit daily activities, or both. Heart disease, cancer, diabetes, obesity, chronic kidney disease, Alzheimer’s disease, arthritis, and chronic obstructive pulmonary disease (COPD) dominate this category. According to the CDC’s updated Fast Facts on Health and Economic Costs of Chronic Conditions (2026), an estimated 90% of the nation’s $4.9 trillion in annual healthcare expenditures are now tied to people living with chronic illnesses and mental health conditions — a figure that has become one of the most cited statistics in American public health. 60% of US adults have at least one chronic condition, and a staggering 40% live with two or more — a reality that drives up per-patient costs, complicates treatment, and compounds year after year as the population ages.
What distinguishes the cost of chronic disease in the US in 2026 from any prior era is the convergence of long-term trends that have now matured simultaneously. The baby boomer cohort — now aged 62 to 80 — represents both the largest and the sickest generation in US history by sheer volume of chronic conditions. Younger adults are acquiring chronic conditions earlier than prior generations, fueled by rising obesity rates, sedentary lifestyles, and ultra-processed food consumption. The Partnership to Fight Chronic Disease (PFCD), in a landmark December 2025 report produced with GlobalData, projected that chronic disease is on pace to cost the US a cumulative $47 trillion between 2024 and 2039 — including $2.2 trillion annually in direct medical costs and nearly $900 billion per year in lost productivity by 2039. These are not worst-case scenarios. They are central projections, built on current trajectory data, and they represent the most consequential fiscal challenge in the history of American healthcare.
Interesting Facts About the Cost of Chronic Disease in the US 2026
CHRONIC DISEASE COST FAST FACTS — US 2026
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
$4.9 Trillion/yr ████████████████████ total US healthcare spending (CDC 2026)
90% ████████████████████ share tied to chronic & mental health conditions
$47 Trillion ████████████████████ projected 15-yr cumulative cost 2024–2039 (PFCD/GlobalData)
$2.2 Trillion/yr ████████████████████ projected annual medical cost by 2039 (PFCD)
$900 Billion/yr ████████████████████ projected productivity loss by 2039 (PFCD)
60% of US adults ████████████████████ have at least 1 chronic condition (CDC)
40% of US adults ████████████████████ have 2+ chronic conditions (CDC)
5% of patients ████████████████████ account for ~50% of all healthcare spending
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
| Interesting Fact | Detail / Data | Source |
|---|---|---|
| 90% of $4.9T in US healthcare spending | Roughly 90% of the nation’s $4.9 trillion in annual healthcare expenditure is tied to chronic illness and mental health | CDC Fast Facts: Health & Economic Costs of Chronic Conditions, 2026 |
| $47 trillion projected cost 2024–2039 | Chronic disease on pace to cost the US $47 trillion over the next 15 years | PFCD / GlobalData December 2025 |
| $2.2 trillion annually in medical costs by 2039 | Direct medical costs alone expected to hit $2.2 trillion per year by 2039 | PFCD / GlobalData December 2025 |
| $900 billion/year in lost productivity by 2039 | Indirect productivity losses projected to hit nearly $900 billion per year by 2039 | PFCD / GlobalData December 2025 |
| 5% of patients account for ~50% of spending | The highest-need 5% of Americans drive approximately 50% of all healthcare spending, largely chronic disease patients | PFCD / GlobalData December 2025 |
| 60% of US adults have ≥1 chronic condition | ~200 million Americans live with at least one chronic condition | CDC, 2026 |
| 40% of US adults have ≥2 chronic conditions | Multiple chronic conditions dramatically multiply individual and system costs | CDC, 2026 |
| $12,900 per US resident by 2039 | Combined per-person medical and productivity cost of chronic disease could reach $12,900 per US resident if no action is taken | PFCD / GlobalData December 2025 |
| $192 billion/year from physical inactivity alone | Inadequate physical activity costs the US $192 billion annually in related healthcare | CDC Fast Facts 2026 |
| Cardiovascular disease costs projected to triple by 2050 | CVD costs will rise from ~$400 billion today to $1.344 trillion by 2050 | American Heart Association Presidential Advisory, Circulation 2024 |
| Only 2 in 5 young adults qualify militarily | Obesity and chronic illness mean only 2 in 5 young adults are weight-eligible for basic US military training | CDC Fast Facts 2026 |
| FY 2026 federal chronic disease budget: $33 million | US government allocated $33 million for chronic disease interventions in FY 2026 — a fraction of the burden | Definitive HC, September 2025 |
Source: CDC Fast Facts: Health and Economic Costs of Chronic Conditions (updated 2026); Partnership to Fight Chronic Disease (PFCD) / GlobalData Report, December 2025; American Heart Association Presidential Advisory, Circulation 2024; Definitive HC, September 2025
The scope of the numbers in this table is genuinely difficult to absorb. The fact that 90% of $4.9 trillion in annual US healthcare spending flows to people managing chronic and mental health conditions means that the entire conversation about healthcare affordability in America — insurance premiums, deductibles, federal entitlement spending, employer benefits costs — is fundamentally a conversation about chronic disease. And the trajectory is worsening, not stabilizing. The PFCD/GlobalData December 2025 projection of $47 trillion in cumulative costs between 2024 and 2039 is not a shock statistic designed to alarm; it is a mathematically derived forecast from current prevalence trends, aging demographic curves, and known cost-per-patient trajectories. At $2.2 trillion per year in direct medical costs by 2039, chronic disease alone would consume a share of US GDP comparable to the entire defense budget today.
The $33 million federal budget allocation for chronic disease interventions in FY 2026 is perhaps the starkest illustration of the policy gap. Against a $4.9 trillion annual healthcare bill, a $33 million prevention budget represents less than 0.001% of the problem it is meant to address. The CDC’s own data shows that physical inactivity alone — one preventable behavioral risk factor — costs the nation $192 billion per year in healthcare. The arithmetic of prevention versus treatment in the US in 2026 is not ambiguous: the country is spending enormously on the consequences of chronic disease while investing almost nothing in preventing them.
Cost of Cardiovascular Disease in the US 2026 | America’s Most Expensive Chronic Condition
CARDIOVASCULAR DISEASE COST BURDEN — US 2026
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Current total CVD costs (direct+indirect) >$500B/yr ████████████████████
Direct healthcare costs (CVD) $223.2B/yr █████████████████
Indirect costs (CVD mortality) $191.5B/yr ████████████████
Atrial fibrillation alone $26B/yr █████████
CVD projected cost by 2035 $1.1T/yr ████████████████████
CVD projected cost by 2050 $1.8T/yr ████████████████████
Americans with some form of CVD by 2050 184M+ ████████████████████
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
| Cardiovascular Disease Cost Metric | US Data | Source |
|---|---|---|
| Annual deaths from heart disease or stroke | More than 850,000 Americans died of heart disease or stroke in 2024 — more than 1 in 4 deaths | CDC Fast Facts 2026 |
| Annual direct healthcare costs of CVD | $223.2 billion per year | CDC Fast Facts 2026; AHA 2026 Statistics Update |
| Annual indirect costs (CVD mortality) | $191.5 billion per year | CDC Fast Facts 2026 |
| Total current CVD cost (direct + indirect) | Exceeds $500 billion per year | American Journal of Cardiology, April 2026 |
| Cardiovascular disease expenditures exceed | $400 billion annually in healthcare costs alone (AHA 2026 update figure) | AHA 2026 Heart Disease & Stroke Statistics / Cardiovascular Diabetology, April 2026 |
| Atrial fibrillation annual cost | $26 billion per year, driven by hospitalizations and anticoagulation management | Cardiovascular Diabetology / PMC, April 2026 |
| CVD cost projection by 2035 | Projected to exceed $1.1 trillion per year | American Journal of Cardiology, April 2026; AHA Circulation 2024 |
| CVD cost projection by 2050 | $1.8 trillion per year (AHA Presidential Advisory); health care costs of CVD risk factors tripling from $400B to $1.344T | AHA Presidential Advisory / Circulation 2024; AHA Newsroom June 2024 |
| Americans projected to have CVD by 2050 | More than 184 million people — exceeding 61% of the US population | AHA Presidential Advisory / AHA Newsroom June 2024 |
| Nearly half of US adults already have CVD (incl. hypertension) | ~50% of US adults now meet criteria for cardiovascular disease when hypertension is included | Cardiovascular Diabetology, April 2026; AHA 2026 Statistics Update |
Source: CDC Fast Facts: Health and Economic Costs of Chronic Conditions 2026; American Heart Association 2026 Heart Disease and Stroke Statistics Update (Circulation); AHA Presidential Advisory on Forecasting CVD Economic Burden, Circulation 2024; American Journal of Cardiology April 2026; Cardiovascular Diabetology / PMC April 2026
Cardiovascular disease (CVD) in the US in 2026 has completed a fundamental transformation: it is no longer primarily an acute, episodic illness that strikes individuals — it is now a chronic, multisystem, lifelong condition affecting nearly half of all American adults. The 2026 AHA Heart Disease and Stroke Statistics Update — the most comprehensive annual cardiovascular surveillance report in the world — makes clear that despite decades of pharmacologic innovation, guideline refinement, and procedural advances, CVD prevalence continues to rise because survival has improved while incidence has not fallen. The result is a growing pool of patients requiring ongoing, expensive management. More than 850,000 Americans died of heart disease or stroke in 2024 alone — more than one in four deaths — and the annual cost to the US healthcare system now exceeds $400–500 billion depending on which cost components are included.
The forward projection is the most alarming dimension of this data. The American Heart Association’s Presidential Advisory, published in Circulation in 2024 and confirmed by the 2026 Statistics Update, projects that CVD-related health care costs will nearly triple from ~$400 billion to $1.344 trillion by 2050 — and total CVD costs including productivity losses will approach $1.8 trillion annually. By that point, more than 184 million Americans — over 61% of the US population — will have some form of cardiovascular disease. These projections are not based on pessimistic assumptions; they are central-case estimates derived from demographic aging, the rising prevalence of metabolic risk factors, and known disease progression patterns. The $26 billion annual cost of atrial fibrillation alone — a single cardiac arrhythmia — illustrates how individual conditions within the CVD umbrella carry financial weights that would strain the budgets of most countries.
Cost of Diabetes, Obesity & Cancer in the US 2026 | The “Big Three” Chronic Conditions
BIG THREE CHRONIC CONDITION COSTS — US 2026
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Diabetes (total cost 2022) $640B ████████████████████
Obesity (employer annual costs) $425B+ ████████████████████
Cancer care cost by 2030 $240B+ ████████████████████
Obesity – higher medical costs $147B ████████████████
Obesity – reduced productivity $160B ████████████████
Obesity – missed workdays $82B █████████████
Cancer – current annual cost $208.9B █████████████████
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
| Condition | Cost Metric | US Data | Source |
|---|---|---|---|
| Diabetes | Total annual cost (medical + productivity loss) | $640 billion in 2022 | CDC Fast Facts 2026; Diabetes Care 2025 |
| Diabetes | Number of Americans with diagnosed diabetes | More than 40.1 million Americans | CDC National Diabetes Statistics Report 2026 |
| Prediabetes | Adults at risk for type 2 diabetes | 115.2 million US adults have prediabetes | CDC National Diabetes Statistics Report 2026 |
| Diabetes | State-level economic costs assessed 2021 | State-by-state economic costs published in Diabetes Care, 2025 | Khavjou et al., Diabetes Care 2025 |
| Obesity | Prevalence — adults | 40% of US adults are obese | CDC Fast Facts 2026 |
| Obesity | Prevalence — children | 21% of US children are obese | CDC Fast Facts 2026 |
| Obesity | Annual cost to the US economy (CDC) | Obesity costs the US economy an enormous annual sum; medical costs for obese adults are $1,800–$2,000/yr higher per person vs. healthy weight | CDC Fast Facts 2026 |
| Obesity (employer) | Higher medical costs for employees + dependents | $146.5 billion per year | Nutrition & Diabetes / Nature, December 2024 |
| Obesity (employer) | Reduced productivity (presenteeism) from obesity | $160.3 billion per year | Nutrition & Diabetes / Nature, December 2024 |
| Obesity (employer) | Missed workdays (absenteeism) cost | $82.3 billion per year | Nutrition & Diabetes / Nature, December 2024 |
| Obesity (employer) | Higher disability costs | $31.1 billion per year | Nutrition & Diabetes / Nature, December 2024 |
| Cancer | Projected annual care cost by 2030 | Over $240 billion by 2030 (up from $208.9 billion projected in 2020) | CDC Fast Facts 2026 |
| Cancer | New cases projected 2025 | Over 2 million new cancer cases in 2025 | CDC / US Cancer Statistics Data Visualizations Tool, updated June 2025 |
| Arthritis | Annual attributable medical expenditure + earnings losses | $300 billion (CDC referenced) | CDC Fast Facts 2026 / Healthgrades June 2025 |
Source: CDC Fast Facts: Health and Economic Costs of Chronic Conditions 2026; CDC National Diabetes Statistics Report 2026; Khavjou et al., Diabetes Care 2025 (peer-reviewed); Nutrition & Diabetes / Nature December 2024 (employer obesity impact); CDC / US Cancer Statistics Data Visualizations Tool, updated June 2025
When the three biggest chronic disease categories — diabetes, obesity, and cancer — are examined side by side, the sheer financial scale becomes almost incomprehensible. Diabetes alone carried a total annual cost of $640 billion in 2022 in the US — a figure that combines direct medical expenditures with lost productivity and represents the single largest disease-specific economic burden after cardiovascular disease. With 40.1 million Americans already diagnosed and 115.2 million more living with prediabetes, the diabetes cost trajectory heading into the late 2020s and 2030s is steep and accelerating. The 2025 peer-reviewed study in Diabetes Care by Khavjou et al. — the first rigorous state-by-state economic analysis of diabetes costs — confirms that the burden is unevenly distributed geographically, with Southern states carrying disproportionate fiscal weight due to higher prevalence and lower treatment access.
Obesity is the driver quietly sitting behind all of these numbers. With 40% of US adults and 21% of US children now classified as obese, and with obesity as a risk factor or direct cause of cardiovascular disease, type 2 diabetes, several cancers, joint disease, sleep apnea, and depression, its economic reach is pervasive. The December 2024 Nutrition & Diabetes/Nature study documenting $425+ billion in annual employer costs — including $160.3 billion in reduced productivity, $82.3 billion in missed workdays, and $146.5 billion in higher medical costs — makes clear that obesity has become one of the largest single line items in US corporate healthcare spending, surpassing many well-known workplace safety programs by orders of magnitude. Cancer’s approaching $240 billion annual care cost by 2030, combined with over 2 million new diagnoses in 2025, rounds out a picture of three interlocking chronic disease epidemics whose combined cost will reshape US fiscal reality in the decade ahead.
Individual Cost of Chronic Disease in the US 2026 | What Patients Pay
OUT-OF-POCKET COSTS FOR CHRONIC DISEASE — US INDIVIDUALS 2026
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Cardiovascular disease (excess OOP) +$317/yr ████████████████████
Diabetes (excess OOP) +$237/yr ████████████████████
Hypertension (excess OOP) +$150/yr ████████████████████
Cancer (excess OOP) +$144/yr ████████████████████
All 4 conditions (arthritis+DM+CVD+HTN) $20,016/yr total ████████████████
Diabetes alone (ages 18–64) >$1,700/yr OOP ████████████████
Depression (absenteeism cost to employer) $44B/yr ████████████████████
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
| Individual Cost Metric | US Data | Population | Source |
|---|---|---|---|
| Cardiovascular disease — excess annual OOP | +$317 per year above non-CVD peers | Medicare beneficiaries (older adults) | NCBI/NIH (PMC6754145) |
| Diabetes — excess annual OOP | +$237 per year above non-diabetic peers | Medicare beneficiaries | NCBI/NIH (PMC6754145) |
| Hypertension — excess annual OOP | +$150 per year above non-hypertensive peers | Medicare beneficiaries | NCBI/NIH (PMC6754145) |
| Cancer — excess annual OOP | +$144 per year above cancer-free peers | Medicare beneficiaries | NCBI/NIH (PMC6754145) |
| Diabetes OOP — working-age adults | Exceeds $1,700 per year in out-of-pocket costs | Americans aged 18–64 with diabetes | NCBI/NIH |
| All 4 conditions (arthritis + diabetes + CVD + hypertension) | Average total annual healthcare expenditures of $20,016 | Adults with all four conditions | NCBI/NIH (PMC4310713) |
| Diabetes + heart disease combined | Substantially higher than single-condition patients | Adults with multiple conditions | NCBI/NIH (PMC4310713) |
| Depression absenteeism cost to employers | $44 billion per year | US employers, workforce-wide | CedarGate / Gallup-referenced data, 2024 |
| Employees with poor mental health | Nearly 5x more missed workdays than peers with good mental health (19% rate their mental health as “fair” or “poor”) | US workforce | Gallup Survey, cited CedarGate October 2024 |
| Per-employee absenteeism cost range (chronic disease) | $16–$286 per employee per year by employer size and condition | US employers | CDC Preventing Chronic Disease Journal / NCBI |
| Type 2 diabetes (most expensive single condition 2019) | $143.9 billion total spending — #1 most expensive single health condition | All US adults | IHME / University of Washington 2025 analysis |
| Musculoskeletal disorders (#2 most expensive condition) | $108.6 billion total spending — joint pain, osteoporosis | All US adults | IHME / University of Washington 2025 analysis |
Source: NCBI/NIH PMC6754145 (Medicare out-of-pocket chronic disease analysis); NCBI/NIH PMC4310713 (multiple chronic conditions expenditure); Gallup/CedarGate October 2024; CDC Preventing Chronic Disease Journal; Institute for Health Metrics and Evaluation (IHME) / University of Washington 2025 analysis
For individual Americans living with chronic disease in 2026, the financial reality is a relentless accumulation of excess costs that compounds with each additional diagnosis. The NCBI/NIH analysis of Medicare beneficiaries provides the clearest peer-reviewed snapshot of excess out-of-pocket spending by condition: cardiovascular disease adds $317 per year, diabetes adds $237, and hypertension adds $150 — but these figures represent only the out-of-pocket increment above baseline, not total costs, and they apply to a Medicare population whose prescription drugs and hospitalizations are already heavily subsidized. For working-age Americans aged 18–64, the picture is considerably grimmer: those with diabetes alone face out-of-pocket spending exceeding $1,700 per year, and patients managing all four of the most common conditions — arthritis, diabetes, cardiovascular disease, and hypertension — face average total annual healthcare expenditures of $20,016 per person. At that level, chronic disease management consumes a meaningful share of median household income.
The mental health dimension of individual chronic disease cost often receives insufficient attention in purely financial analyses, but the numbers are stark. Gallup’s survey finding that 19% of US employees rate their mental health as “fair” or “poor” — and that those individuals miss nearly 5 times as many workdays as their peers — translates to $44 billion per year in employer absenteeism costs from depression alone. The Institute for Health Metrics and Evaluation (IHME) at the University of Washington, in a landmark 2025 analysis of personal health care spending across 148 conditions from 2010–2019, found that type 2 diabetes was the single most expensive health condition in America at $143.9 billion in total spending, followed by musculoskeletal disorders at $108.6 billion — confirming that the individual financial burden of chronic disease is not abstract: it is paid in real dollars, real lost wages, and real forgone life opportunities by tens of millions of Americans every year.
Chronic Disease Productivity & Workforce Cost in the US 2026 | The Hidden Toll
CHRONIC DISEASE WORKFORCE & PRODUCTIVITY COSTS — US 2026
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
Lost productivity (PFCD est. 2039) ~$900B/yr ████████████████████
Illness-related lost productivity (IBI) $530B/yr ████████████████████
Depression absenteeism (employers) $44B/yr █████████████
Physical inactivity (healthcare cost) $192B/yr ████████████████
Obesity presenteeism (employers) $160B/yr █████████████
Obesity absenteeism (employers) $82B/yr ████████████
Per-person absenteeism cost (obesity) $1,755/yr ████████████████████
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
| Workforce / Productivity Metric | US Data | Source |
|---|---|---|
| Projected annual productivity loss from chronic disease (2039) | ~$900 billion per year in lost productivity by 2039 | PFCD / GlobalData, December 2025 |
| Current illness-related lost productivity — US employers | $530 billion per year — equivalent to 60 cents for every dollar spent on health benefits | Integrated Benefits Institute (IBI) |
| Total sick days / impaired performance days | 893 million sick days + 527 million impaired performance workdays annually | IBI Research |
| Depression absenteeism cost to employers | $44 billion per year | Gallup / CedarGate, 2024 |
| Physical inactivity healthcare cost | $192 billion per year | CDC Fast Facts 2026 |
| Obesity presenteeism (reduced on-job productivity) | $160.3 billion per year to employers | Nutrition & Diabetes / Nature, December 2024 |
| Obesity absenteeism | $82.3 billion per year to employers | Nutrition & Diabetes / Nature, December 2024 |
| Per-person obesity absenteeism cost (employer) | $1,755 per year per employee with obesity | Nutrition & Diabetes / Nature, December 2024 |
| Obesity disability payments (annual) | $31.1 billion per year | Nutrition & Diabetes / Nature, December 2024 |
| Obesity workers’ compensation | $5.2 billion per year | Nutrition & Diabetes / Nature, December 2024 |
| Each chronic disease risk factor (hypertension/diabetes/obesity) | Associated with absenteeism costs greater than $2 billion per year nationally | CDC Preventing Chronic Disease Journal / NCBI |
| Defensive medicine costs (chronic disease-adjacent) | $46 billion per year added to US healthcare due to liability pressures | Medical Economics / NPDB, September 2025 |
Source: Partnership to Fight Chronic Disease (PFCD) / GlobalData December 2025; Integrated Benefits Institute (IBI); CDC Fast Facts: Health and Economic Costs of Chronic Conditions 2026; Nutrition & Diabetes / Nature December 2024; Gallup / CedarGate October 2024; CDC Preventing Chronic Disease Journal / NCBI
The workforce and productivity cost of chronic disease in the US in 2026 represents the dimension most consistently underestimated in policy discussions, because it does not appear directly in healthcare budgets — it appears in reduced GDP, lower tax revenues, higher disability claims, and the quiet economic erosion of millions of working Americans managing conditions that impair their daily capacity. The Integrated Benefits Institute (IBI) has calculated that illness-related lost productivity costs US employers $530 billion per year — roughly 60 cents for every dollar they spend on health benefits. That ratio means the cost of chronic disease is not merely a healthcare problem; it is a total compensation problem, a workforce planning problem, and an economic competitiveness problem. 893 million sick days and 527 million impaired-performance workdays are lost annually in the US workforce — a volume that translates directly into reduced output, increased overtime, higher temporary staffing costs, and burnout among the workers covering for colleagues managing chronic illness.
Obesity’s employer burden alone — $160.3 billion in presenteeism, $82.3 billion in missed workdays, and $31.1 billion in disability payments — totals over $425 billion per year when all components are combined. At $1,755 per employee per year in absenteeism costs alone for workers with obesity, a company with 10,000 employees and a 40% obesity rate — the US adult average — faces a $7 million annual absenteeism bill from that single condition before accounting for higher insurance premiums, disability claims, or reduced productivity. The PFCD/GlobalData projection of nearly $900 billion per year in productivity losses from chronic disease by 2039 is not a distant alarm — it is the mathematically inevitable destination of the current trajectory, absent meaningful investment in prevention, chronic disease management programs, workplace wellness infrastructure, and equitable access to care for the millions of Americans for whom early intervention remains out of reach.
Disclaimer: The data research report we present here is based on information found from various sources. We are not liable for any financial loss, errors, or damages of any kind that may result from the use of the information herein. We acknowledge that though we try to report accurately, we cannot verify the absolute facts of everything that has been represented.
